Showing results (31-40 of 602) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2013
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1aAnna Karin Hedström, Malin Ryner, Katarina Fink, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
Annals of Clinical and Translational Neurology|May 13, 2022
Copy number variations across the blood-brain barrier in multiple sclerosisSahl Khalid Bedri, Björn Evertsson, Mohsen Khademi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2014
Age-dependent effects on the treatment response of natalizumab in MS patientsHenrik Matell, Jan Lycke, Anders Svenningsson, et al.
International Journal of Epidemiology|January 11, 2023
Association between exposure to combustion-related air pollution and multiple sclerosis riskAnna Karin Hedström, David Segersson, Jan Hillert, et al.
Brain : a Journal of Neurology|February 10, 2011
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosisAnna Karin Hedström, Emilie Sundqvist, Maria Bäärnhielm, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2017
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disabilityAndrius Kavaliunas, Virginija Danylaite Karrenbauer, Hanna Gyllensten, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2017
Multiple sclerosis treatment effects on plasma cytokine receptor levelsSahl Khalid Bedri, Katharina Fink, Ali Manouchehrinia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2022
Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort studyKelsi A Smith, Fredrik Piehl, Tomas Olsson, et al.
Pageof 61